Skin testing with β-lactam antibiotics for diagnosis of β-lactam hypersensitivity in children

Wiparat Manuyakorn1, Prapasiri Singvijarn1, Suwat Benjaponpitak1

  • 1Division of Pediatrics Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Abstract

Insights

Skin testing with beta-lactam antibiotics is safe for children with a history of hypersensitivity. While these tests have a good negative predictive value (NPV), drug provocation tests are still needed for accurate diagnosis.

Area of Science:

  • Allergy and Immunology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Penicilloyl-polylysine (PPL) and minor determinant mixture (MDM) were standard for beta-lactam hypersensitivity testing but are unavailable.
  • Accurate diagnosis of beta-lactam hypersensitivity is crucial, especially in pediatric populations.

Purpose of the Study:

  • To determine the negative predictive value (NPV) of skin testing with common beta-lactam antibiotics for diagnosing hypersensitivity.
  • To assess the safety and efficacy of alternative skin testing methods in children.

Main Methods:

  • Evaluated 126 pediatric patients (ages 1-18) with a history of beta-lactam hypersensitivity.
  • Performed skin tests (prick and intradermal) with penicillin G, ampicillin, amoxicillin-clavulanic acid, and the suspected beta-lactam.
  • Conducted a 3-dose-graded drug provocation test (DPT) for patients with negative skin tests.

Main Results:

  • Twenty-two patients (17.4%) had confirmed beta-lactam hypersensitivity; 12 were identified via skin testing.
  • No systemic reactions occurred during skin testing.
  • Ten patients (9.6%) with negative skin tests reacted to DPT, yielding an NPV of 91.2% for skin testing.

Conclusions:

  • Skin testing with beta-lactam antibiotics is a safe and viable option for diagnosing hypersensitivity in children when PPL and MDM are unavailable.
  • Skin testing alone has insufficient sensitivity; DPT is essential for confirming beta-lactam hypersensitivity diagnoses.